Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II–IV peripheral T‐cell lymphoma
暂无分享,去创建一个
R. Advani | J. Vose | Luu Q. Pham | S. Ansell | S. Horwitz | M. Lunning | H. Lee | J. Zain | N. Mehta-Shah | A. Moskowitz | M. Lechowicz | B. Haverkos | Robert N Stuver | Elizabeth Leyden